| 英文名称 | 中文名称 | CAS | MF |
|
METHYL TRANS-CINNAMATE-D7
|
METHYL TRANS-CINNAMATE-D7
|
2022152-96-9
|
C10H10O2
|
|
5,5-difluoro-2,8-diformyl-1,3,7,9-tetramethyl-10-phenyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide
|
5,5-difluoro-2,8-diformyl-1,3,7,9-tetramethyl-10-phenyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide
|
2022166-57-8
|
C21H19BF2N2O2
|
|
E3 Ligand-Linker Conjugate 6
|
E3 Ligand-Linker Conjugate 6
|
2022182-57-4
|
C18H20N4O6
|
|
Thalidomide-O-amido-C3-NH2 (TFA)
|
Thalidomide-O-amido-C3-NH2 (TFA)
|
2022182-58-5
|
C20H21F3N4O8
|
|
E3 Ligand-Linker Conjugate 7
|
E3 Ligand-Linker Conjugate 7
|
2022182-59-6
|
C19H22N4O7
|
|
(4-bromothiophen-3-yl)(piperidin-1-yl)methanone
|
(4-溴噻吩-3-基)(哌啶-1-基)甲酮
|
2022184-92-3
|
C10H12BrNOS
|
|
S-(difluoromethyl) benzenesulfonothioate
|
二氟甲基硫代苯磺酸酯
|
2022186-75-8
|
C7H6F2O2S2
|
|
3,3'-Bi-9H-carbazole, 9-(2-naphthalenyl)-
|
9-(萘-2-基)-9H,9'H-3,3'-联咔唑
|
2022222-83-7
|
C34H22N2
|
|
2-(9H-Carbazol-3-yl)-5-phenyl-5H-benzo[b]carbazole
|
|
2022222-86-0
|
C34H22N2
|
|
2022918-38-1
|
2022918-38-1
|
2022918-38-1
|
C37H70O6Si2
|
|
Nim-Benzyl-D-histidine
|
Nim-Benzyl-D-histidine
|
2022956-35-8
|
C13H15N3O2
|
|
Fmoc-Ala-Cys[Psi(Dmp,H)Pro]-OH
|
FMOC-ALA-CYS(PSI(DMP,H)PRO)-OH
|
2022956-37-0
|
C30H30N2O7S
|
|
Fmoc-Lys(Boc)-Cys(Psi(Me,Me)pro)-OH
|
Fmoc-Lys(Boc)-Cys(Psi(Me,Me)pro)-OH
|
2022956-38-1
|
C32H41N3O7S
|
|
Biotinyl-CBP501 Affinity Peptide
|
BIOTINYL-CBP501 AFFINITY PEPTIDE
|
2022956-39-2
|
C78H133N23O27S2
|
|
H-Gly-Gly-Arg-Ser-Pro-Ala-Met-Pro-Glu-OH
|
H-GLY-GLY-ARG-SER-PRO-ALA-MET-PRO-GLU-OH
|
2022956-40-5
|
C36H60N12O13S
|
|
H-Thr-Pro-Asn-Gln-Arg-Gln-Asn-Val-Cys-OH
|
H-THR-PRO-ASN-GLN-ARG-GLN-ASN-VAL-CYS-OH TRIFLUOROACETATE SALT
|
2022956-41-6
|
C41H70N16O15S
|
|
H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Leu-Tyr-Arg-Ser-Pro-Ala-Ser-Met-Pro-Glu-Asn-Leu-OH
|
|
2022956-42-7
|
C124H212N48O32S
|
|
Cyclo(-Gly-Arg-Gly-Glu-Ser-Pro)
|
Cyclo(-Gly-Arg-Gly-Glu-Ser-Pro)
|
2022956-43-8
|
C23H37N9O9
|
|
FITC-εAhx-Gly-Arg-Gly-Asp-Ser-Pro-OH
|
FITC-εAhx-Gly-Arg-Gly-Asp-Ser-Pro-OH
|
2022956-44-9
|
C49H59N11O16S
|
|
Biotinyl-εAhx-Gly-Arg-Gly-Asp-Ser-OH
|
BIOTINYL-ΕAHX-GLY-ARG-GLY-ASP-SER-OH TRIFLUOROACETATE SALT
|
2022956-45-0
|
C33H55N11O12S
|
|
(Glu20)-Glucagon (1-29) (human, rat, porcine)
|
胰高血糖素杂质 4 四三氟乙酸 GLU 20-胰高血糖素)
|
2022956-46-1
|
C153H224N42O50S
|
|
Biotinyl-KR-12 (human)
|
BIOTINYL-KR-12 (HUMAN)
|
2022956-47-2
|
C81H140N26O18S
|
|
Myelin Oligodendrocyte Glycoprotein (35-55) amide (rat, mouse)
|
MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55) AMIDE (RAT, MOUSE) TRIFLUOROACETATE SALT
|
2022956-48-3
|
C118H178N36O28S
|
|
Orexin A (1-15) (free acid)
|
OREXIN A (1-15) (FREE ACID) TRIFLUOROACETATE SALT
|
2022956-49-4
|
C67H109N23O22S4
|
|
Acetyl-PHF4 amide
|
Acetyl-PHF4 amide
|
2022956-50-7
|
C28H46N6O6
|
|
Acetyl-PHF6IV amide
|
ACETYL-PHF6IV AMIDE
|
2022956-51-8
|
C37H61N9O9
|
|
Acetyl-PHF6QV amide
|
ACETYL-PHF6QV AMIDE
|
2022956-52-9
|
C38H64N8O8
|
|
Tau Peptide (1-16)
|
Tau Peptide (1-16)
|
2022956-53-0
|
C77H120N20O28S3
|
|
Tau Peptide (45-73) (Exon 2/Insert 1 Domain)
|
TAU PEPTIDE (45-73) (EXON 2/INSERT 1 DOMAIN)
|
2022956-54-1
|
C120H189N31O57
|
|
(Ser(POH)22,Thr(POH)2)-Tau Peptide (194-213)
|
(Ser(POH)22,Thr(POH)2)-Tau Peptide (194-213)
|
2022956-55-2
|
C81H133N29O36P2
|
|
Acetyl-Tau Peptide (244-274) (Repeat 1 Domain)
|
ACETYL-TAU PEPTIDE (244-274) (REPEAT 1 DOMAIN)
|
2022956-56-3
|
C143H240N42O45S
|
|
(Ser(POH)22)-Tau Peptide (260-264) PAb Blocking
|
(SER(POH)22)-TAU PEPTIDE (260-264) PAB BLOCKING
|
2022956-57-4
|
C20H36N5O13P
|
|
Biotinyl-Tau Peptide (306-336) (Repeat 3 Domain)
|
BIOTINYL-TAU PEPTIDE (306-336) (REPEAT 3 DOMAIN)
|
2022956-58-5
|
C153H250N44O44S2
|
|
Tau Peptide (323-335)
|
TAU PEPTIDE (323-335)
|
2022956-59-6
|
C60H103N21O20
|
|
(Ser(POH)3·)-Tau Peptide (379-408)
|
(SER(POH)3)-TAU PEPTIDE (379-408)
|
2022956-60-9
|
C140H230N44O52P2
|
|
Tau Peptide (512-525) amide
|
TAU PEPTIDE (512-525) AMIDE
|
2022956-61-0
|
C51H77N15O21
|
|
T-Peptide
|
T-PEPTIDE
|
2022956-62-1
|
C92H171N45O18
|
|
HHV-2 Envelope Glycoprotein G (552-574)
|
HHV-2 ENVELOPE GLYCOPROTEIN G (552-574)
|
2022956-63-2
|
C103H146N28O38
|
|
FITC-εAhx-HHV-2 Envelope Glycoprotein G (561-578)
|
FITC-εAhx-HHV-2 Envelope Glycoprotein G (561-578)
|
2022956-64-3
|
C104H128N20O44S
|
|
(Lys(Ac)5.8.12.16)-Histone H4 (1-25)-Gly-Ser-Gly-Ser-Lys(biotinyl)
|
(LYS(AC)···)-HISTONE H4 (1-25)-GLY-SER-GLY-SER-LYS(BIOTINYL) TRIFLUOROACETATE SALT
|
2022956-65-4
|
C141H243N53O43S
|
|
(Lys(Ac)12)-Histone H4 (1-21)-Gly-Gly-Lys(biotinyl)
|
(LYS(AC))-HISTONE H4 (1-21)-GLY-GLY-LYS(BIOTINYL) TRIFLUOROACETATE SALT
|
2022956-66-5
|
C111H195N43O30S
|
|
(Lys(Me)32)-Histone H3 (21-44)-Gly-Lys(biotinyl)
|
(LYS(ME))-HISTONE H3 (21-44)-GLY-LYS(BIOTINYL) TRIFLUOROACETATE SALT
|
2022956-67-6
|
C130H221N44O33S+
|
|
(Lys(Me)2)-Histone H3 (1-21)-Gly-Gly-Lys(biotinyl)
|
(LYS(ME))-HISTONE H3 (1-21)-GLY-GLY-LYS(BIOTINYL) TRIFLUOROACETATE SALT
|
2022956-70-1
|
C116H208N42O33S
|
|
(Lys(Me)3)-Histone H3 (1-21)-Gly-Gly-Lys(biotinyl) amide
|
(LYS(ME))-HISTONE H3 (1-21)-GLY-GLY-LYS(BIOTINYL) AMIDE TRIFLUOROACETATE SALT
|
2022956-73-4
|
C117H212N43O32S+
|
|
Fmoc-Cys(Trt)-Cys(Psi(Dmp,H)pro)-OH≥ 98% (HPLC,TLC)
|
|
2022956-75-6
|
C49H44N2O7S2
|
|
Raphin1
|
(E)-3-[(2,3-二氯苯基)亚甲基]氨基胍
|
2022961-17-5
|
C8H8Cl2N4
|
|
(D-Asn28)-Exenatide
|
(D-ASN2)-EXENATIDE TRIFLUOROACETATE SALT
|
2022972-66-1
|
|
|
(D-Asp28)-Exenatide
|
(D-ASP2)-EXENATIDE TRIFLUOROACETATE SALT
|
2022972-67-2
|
|
|
(β-Asp28)-Exenatide
|
(Β-ASP2)-EXENATIDE TRIFLUOROACETATE SALT
|
2022972-68-3
|
|
|
LL-37 (37-1)
|
LL-37 (37-1)
|
2022972-70-7
|
|
|
Biotinyl-εAhx-LL-37 (scrambled)
|
BIOTINYL-ΕAHX-LL-37 (SCRAMBLED)
|
2022972-72-9
|
|
|
5-FAM-LL-37 (scrambled)
|
5-FAM-LL-37 (SCRAMBLED)
|
2022972-73-0
|
|
|
Tyr-LL-37
|
TYR-LL-37
|
2022972-74-1
|
|
|
(Lauroyl-Cys-Tyr-Gly(-Glu-Glu-Asn-Val)-OH) (Disulfide bond)
|
(LAUROYL-CYS-TYR-GLY(-GLU-GLU-ASN-VAL)-OH) (DISULFIDE BOND)
|
2022972-75-2
|
|
|
Biotinyl-(Gln1)-Orexin A (human, mouse, rat)
|
BIOTINYL-(GLN)-OREXIN A (HUMAN, MOUSE, RAT) TRIFLUOROACETATE SALT
|
2022973-13-1
|
|
|
Lys-Trp-Lys-(Ser(GlcNAc-β-D))-Tau Peptide (388 - 411)-Lys-Lys(biotinyl) amide
|
LYS-TRP-LYS-(SER(GLCNAC-Β-D))-TAU PEPTIDE (388 - 411)-LYS-LYS(BIOTINYL) AMIDE
|
2022974-40-7
|
|
|
(Cys(Acm)6.12)-Orexin A (human, mouse, rat)
|
(CYS(ACM)·)-OREXIN A (HUMAN, MOUSE, RAT) TRIFLUOROACETATE SALT
|
2022974-96-3
|
|
|
3-Quinolinecarbonitrile, 7-bromo-2,4,6-trichloro-8-fluoro-
|
7-溴-2,4,6-三氯-8-氟喹啉-3-碳腈
|
2022976-02-7
|
C10HBrCl3FN2
|
|
(β-D-Asp28)-Exenatide
|
(Β-D-ASP28)-艾塞那肽
|
2022976-04-9
|
|
|
(5-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-4-yl)boronic acid
|
(5-甲基-1-(四氢-2H-吡喃-2-基)-1H-吲唑-4-基)硼酸
|
2022976-34-5
|
C13H17BN2O3
|
|
4-METHOXYCARBONYL-2,6-DIFLUOROPHENYLBORONIC ACID
|
4-METHOXYCARBONYL-2,6-DIFLUOROPHENYLBORONIC ACID
|
2022984-58-1
|
C8H7BF2O4
|
|
4,7-dibromo-5,6-bis((2-butyloctyl)oxy)benzo[c][1,2,5]thiadiazole
|
PM242
|
2022985-69-7
|
C30H50Br2N2O2S
|
|
Tau Peptide (255-314) (Repeat 2 Domain)
|
TAU PEPTIDE (255-314) (REPEAT 2 DOMAIN)
|
2022995-68-0
|
|
|
6-Oxa-5-thia-4-azaspiro[2.4]heptane-4-carboxylic acid, 1,1-dimethylethyl ester, 5,5-dioxide
|
6-Oxa-5-thia-4-azaspiro[2.4]heptane-4-carboxylic acid, 1,1-dimethylethyl ester, 5,5-dioxide
|
2023006-14-4
|
C9H15NO5S
|
|
tert-butyl (4S)-4-(methoxymethyl)-2,2-dioxo-oxathiazolidine-3-carboxylate
|
tert-butyl (4S)-4-(methoxymethyl)-2,2-dioxo-oxathiazolidine-3-carboxylate
|
2023006-41-7
|
C9H17NO6S
|
|
(R)-GNA-C(Bz)-phosphoramidite
|
化合物 (R)-GNA-C(BZ)-PHOSPHORAMIDITE
|
2023779-58-8
|
C44H50N5O7P
|
|
Tirzepatide
|
替尔泊肽
|
2023788-19-2
|
C225H348N48O68
|
|
Boronic acid, B,?B'-?(4,?8-?diethoxybenzo[1,?2-?b:4,?5-?b']?dithiophene-?2,?6-?diyl)?bis-
|
(4,8-二乙氧基苯并[1,2-B:4,5-B']二噻吩-2,6-二基)二硼酸
|
2023811-72-3
|
C14H16B2O6S2
|
|
Scillascillol
|
Scillascillol
|
2023822-39-9
|
C30H46O6
|
|
Scillascillone
|
Scillascillone
|
2023822-40-2
|
C30H44O6
|
|
Scillascilloside B-1
|
Scillascilloside B-1
|
2023822-41-3
|
C40H64O13
|
|
6-Quinolinecarboxylic acid, 4-hydroxy-7-methoxy-, methyl ester
|
6-Quinolinecarboxylic acid, 4-hydroxy-7-methoxy-, methyl ester
|
2023826-82-4
|
C12H11NO4
|
|
9,9'-Spirobi[fluoren]-2-yltributylstannane
|
9,9'-螺二芴-2-三丁基锡
|
2023839-51-0
|
C37H42Sn
|
|
6-chloropyrazolo[1,5-a]pyrimidine
|
6-chloropyrazolo[1,5-a]pyrimidine
|
2024538-64-3
|
C6H4ClN3
|
|
Lin28-IN-1
|
Lin28-IN-1
|
2024548-03-4
|
C31H29N5O7
|
|
(1S,2S,3S,5R)-3-(2-Hydroxyethoxy)-5-[7-methoxy-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-1,2-cyclopentanediol
|
(1S,2S,3S,5R)-3-(2-Hydroxyethoxy)-5-[7-methoxy-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-1,2-cyclopentanediol
|
2024557-22-8
|
C15H23N5O5S
|
|
[BIS(HYDROXYETHYL)AMINE] TERMINATED POLYDIMETHYLSILOXANE, 120-160 cSt
|
|
2024596-86-7
|
|
|
Oleylammonium
Bromide
|
油胺溴
|
2024602-96-6
|
C18H38BrN
|
|
Atracurium Impurity 16
|
Atracurium Impurity 16
|
2024603-91-4
|
C52H69N2O12+
|
|
GDZISNMJFAJFMR-BEQCQUFHSA-M
|
阿区库铵去甲基杂质
|
2024603-92-5
|
C58H74N2O15S
|
|
Edoxaban Impurity 9(1R,2S,4S)
|
依度沙班杂质9
|
2024614-15-9
|
C21H30ClN5O5
|
|
Edoxaban Impurity 24 (1S,2S,4R)
|
Edoxaban Impurity 24 (1S,2S,4R)
|
2024614-21-7
|
C21H30ClN5O5
|
|
Edoxaban Impurity 22 (1S,2R,4R)
|
Edoxaban Impurity 22 (1S,2R,4R)
|
2024614-32-0
|
C21H30ClN5O5
|
|
Cyclobutanecarboxylic acid, 1-[[(9H-fluoren-9-ylmethoxy)carbonyl]methylamino]-3,3-dimethyl-
|
|
2025106-27-6
|
C23H25NO4
|
|
Benzenemethanol, 4,4'-(1,2-diphenyl-1,2-ethenediyl)bis-
|
((1,2-二苯基乙烯-1,2-二基)双(4,1-亚苯基))二甲醇
|
2025340-31-0
|
C28H24O2
|
|
Obeticholic Acid-[d4]
|
Obeticholic Acid-[d4]
|
2025364-15-0
|
C26H44O4
|
|
2-bromo-4-phenyldibenzo[b,d]furan
|
2-溴-4-苯基二苯并[B,D]呋喃
|
2025367-17-1
|
C18H11BrO
|
|
Benzo[b]naphtho[2,3-d]furan, 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
|
Benzo[b]naphtho[2,3-d]furan, 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
|
2025367-45-5
|
C22H21BO3
|
|
L-NORVALINOL HCl
|
(S)-2-氨基戊烷-1-醇盐酸盐
|
2025376-01-4
|
C5H14ClNO
|
|
(3R,4R)-1-benzyl-4-methylpiperidin-3-amine
|
托法替尼杂质64
|
2026634-40-0
|
C13H20N2
|
|
[2H5]-Loteprednol Etabonate
|
[2H5]-LOTEPREDNOL ETABONATE
|
2026643-11-6
|
C24H31ClO7
|
|
Benzoic acid, 3-hydroxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, methyl ester
|
3-羟基-4-(4,4,5,5-四甲基-1,3,2-二氧硼烷-2-基)苯甲酸甲酯
|
2026647-81-2
|
C14H19BO5
|
|
1,3,5-Trimethyl-2,4,6-Tris(4-pyridyl)benzene
|
1,3,5-三甲基-2,4,6-三 (4-吡啶基)苯
|
2027486-17-3
|
C24H21N3
|
|
2-AMINO-2-(2-CHLOROPHENYL)ETHAN-1-OL HYDROCHLORIDE
|
2027496-47-3
|
2027496-47-3
|
C8H11Cl2NO
|
|
6-azaspiro[3.4]octan-2-ol hydrochloride
|
6-氮杂螺[3.4]辛-2-醇盐酸盐
|
2027496-49-5
|
C7H14ClNO
|
|
Methyl {[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]oxy}acetate
|
6-(2-甲氧基-2-氧代乙氧基)-3-吡啶硼酸频哪醇酯
|
2027496-50-8
|
C14H20BNO5
|
|
2,6-Difluoro-3-methylsulfanyl-benzoic acid methyl ester
|
4-FLUORO-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID PINACOL ESTER
|
2027537-27-3
|
C9H8F2O2S
|
|
4-[(3-Chloro-2,6-difluorophenyl)methyl]morpholine
|
4-[(3-氯-2,6-二氟苯基)甲基]吗啉
|
2027537-28-4
|
C11H12ClF2NO
|
|
1,3-Dimethyl-5-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxa-borolan-2-yl)-benzyl]-pyrimidine-2,4,6-trione
|
1,3-Dimethyl-5-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxa-borolan-2-yl)-benzyl]-pyrimidine-2,4,6-trione
|
2027543-00-4
|
C19H25BN2O5
|
|
1,3-Dimethyl-5-[3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzylidene]-pyrimidine-2,4,6-tr
|
1,3-Dimethyl-5-[3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzylidene]-pyrimidine-2,4,6-tr
|
2027543-16-2
|
C19H23BN2O5
|